Big Move For Marinus Pharmaceuticals, Inc.
Fri, Oct 25, 2024 at 07:42 PM
Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ) soared at $0.41, a gain of 36.9%. On Fri, Oct 25, 2024, MRNS:NASDAQ touched a New 2-Week Intraday Low of $0.26. The stock appeared on our News Catalysts scanner on Fri, Oct 25, 2024 at 10:28 AM in the 'BIOTECH' category. From Fri, Oct 11, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Sep 24, 2024 at $1.97 with a volume of 3M+.
About Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ)
Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders.
Top 10 Gainers:
- Smart for Life Inc. (SMFL:NASDAQ), 172.09%
- Upexi Inc Com (UPXI:NASDAQ), 170%
- ARB IOT Group Limited (ARBB:NASDAQ), 107.3%
- NWTN Inc. (NWTN:NASDAQ), 62.44%
- Iterum Therapeutics plc (ITRM:NASDAQ), 60.68%
- BM Technologies Inc. (BMTX:NYSEMKT), 47.21%
- Fitell Corporation (FTEL:NASDAQ), 44.39%
- SRAX, Inc. (SRAX:NASDAQ), 40%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 36.86%
- Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 31.01%